Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Health Alert: Worldwide Caution – Updated Public Health Arrival Restrictions and Enhanced Ebola Disease Screening – May 28, 2026 - U.S. Embassy & Consulates in Italy